Renal-cell carcinoma.
Renal-cell carcinoma.
Renal cell carcinoma
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns
Sunitinib in patients with metastatic renal cell carcinoma.
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma: Commentary
Re: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.
EAU Guidelines on Renal Cell Carcinoma: The 2010 Update